These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 5817479)

  • 21. Development of extremely attenuated live measles virus vaccine (CAM-EX).
    Ueda S; Takahashi M; Kurimura T; Minekawa Y; Suzuki N
    Biken J; 1972 Sep; 15(3):173-7. PubMed ID: 4643692
    [No Abstract]   [Full Text] [Related]  

  • 22. [Study on the long-term observation of measles vaccine immunity. 1. End results of vaccination and re-vaccination].
    Tsukada Y
    Nihon Shonika Gakkai Zasshi; 1968 Apr; 72(4):473-87. PubMed ID: 5692409
    [No Abstract]   [Full Text] [Related]  

  • 23. Studies on measles in Thailand. IV. Persistence of measles antibody in the absence of natural virus two years after vaccination by the "KL" method.
    Sangkawibha N; Tsuchida P; Bukkavesa S; Ostanonda P; Ueda S
    Biken J; 1971 Jun; 14(2):149-54. PubMed ID: 5122205
    [No Abstract]   [Full Text] [Related]  

  • 24. Determination of antigenicity of inactivated measles vaccine on guinea pigs.
    Drevo M; Mares I; Závadová H
    J Hyg Epidemiol Microbiol Immunol; 1968; 12(4):389-96. PubMed ID: 5752126
    [No Abstract]   [Full Text] [Related]  

  • 25. [Immunoglobulin classes of antibodies produced by inoculation of attenuated live measles vaccine].
    Sekiguchi H; Numazaki Y; Ikeda M; Yano N
    Iryo; 1970 Jan; 24(1):21-3. PubMed ID: 4191377
    [No Abstract]   [Full Text] [Related]  

  • 26. [Possibilities and limits of vaccinations].
    Schneeweiss B
    Z Arztl Fortbild (Jena); 1971 May; 65(9-10):485-95. PubMed ID: 5114862
    [No Abstract]   [Full Text] [Related]  

  • 27. [Evaluation of the vaccination of a misture of inactivated and live measles vaccines. 1. Clinicoserological observation for a period of 4 years].
    Tanaka H
    Nihon Shonika Gakkai Zasshi; 1972 Mar; 76(3):162-9. PubMed ID: 5065657
    [No Abstract]   [Full Text] [Related]  

  • 28. Development and evaluation of the Moraten measles virus vaccine.
    Hilleman MR; Buynak EB; Weibel RE; Stokes J; Whitman JE; Leagus MB
    JAMA; 1968 Oct; 206(3):587-90. PubMed ID: 5695578
    [No Abstract]   [Full Text] [Related]  

  • 29. [Studies of specific measles prevention].
    Cajal N; Cepleanu M; Sorodoc Y; Cernescu C; Manu S; Weintraub B; Lucian M; Popescu M
    Stud Cercet Inframicrobiol; 1970; 21(3):195-211. PubMed ID: 5455840
    [No Abstract]   [Full Text] [Related]  

  • 30. Vaccination against measles. Clinical trial of live measles vaccine given alone and live vaccine preceded by killed vaccine. Third report to the Medical Research Council by the Measles Vaccines Committee.
    Practitioner; 1971 Apr; 206(234):458-66. PubMed ID: 4930718
    [No Abstract]   [Full Text] [Related]  

  • 31. [Virologic and clinical observations after active measles vaccination. 2].
    Haas R; Vivell O; Buentello-Malo L; Reiss G; Berning D
    Dtsch Med Wochenschr; 1966 Apr; 91(13):569-74. PubMed ID: 5930702
    [No Abstract]   [Full Text] [Related]  

  • 32. Inoculation with D(diphtheria), P(pertussis), T(tetanus), M(measles) or DPTMV(vaccinia) combined vaccine.
    Sagawa I; Yoshida K; Shintani K; Asano S; Hori M
    Z Immunitatsforsch Allerg Klin Immunol; 1970 Nov; 140(5):440-56. PubMed ID: 4249812
    [No Abstract]   [Full Text] [Related]  

  • 33. A study of the protective effect of live measles vaccines 13 to 27 months after vaccination.
    Sejda J; Helcl J; Strauss J; Zdrazílek J; Mírovský J
    J Hyg Epidemiol Microbiol Immunol; 1968; 12(2):187-91. PubMed ID: 5752748
    [No Abstract]   [Full Text] [Related]  

  • 34. [Vaccination against measles].
    Ek E
    Tidsskr Nor Laegeforen; 1971 Jan; 91(2):135-7. PubMed ID: 5539605
    [No Abstract]   [Full Text] [Related]  

  • 35. [Relationship between the age of the child and the degree of body temperature and antibody titre after vaccination against measles].
    Domorázková E; Janotová J; Vodicková M; Drevo M
    Cesk Pediatr; 1975 Oct; 30(10):468-70. PubMed ID: 1212713
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical reactogenicity and immunogenicity of five live measles vaccine strains.
    Chin Med J (Engl); 1981 Apr; 94(4):201-6. PubMed ID: 6790234
    [No Abstract]   [Full Text] [Related]  

  • 37. [Results of the inoculation test of measles vaccine. 1. The result of measles-attenuated live virus vaccine].
    Santo K
    Nihon Shonika Gakkai Zasshi; 1967 Mar; 71(3):332-43. PubMed ID: 4168846
    [No Abstract]   [Full Text] [Related]  

  • 38. Age for measles immunization seroconversion after measles vaccination at 6-8 months of age--a randomized controlled trial.
    Deivanayagam N; Ramamurthy N; Krishnamurthy PV; Shankar VJ; Ashok TP; Nedunchelian K; Mala N; Ahmed SS
    Indian Pediatr; 1990 Nov; 27(11):1171-6. PubMed ID: 2081639
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical laboratory experiences with a more attenuated Enders' measles virus vaccine (Moraten) combined with smallpox vaccine.
    Weibel RE; Stokes J; Buynak EB; Leagus MB; Hilleman MR
    Pediatrics; 1969 Apr; 43(4):567-72. PubMed ID: 4304934
    [No Abstract]   [Full Text] [Related]  

  • 40. [Experiences with the live measles vaccine].
    Vivell O; Lips G
    Arch Kinderheilkd; 1967; 176(2):156-63. PubMed ID: 5592896
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.